Valdecilla brand, created in 1929, has been cited more than 120,000 times by the international biomedical literature, according to data obtained on the Web of Science database. According to these data, papers published by the authors who have in their affiliation the brand Valdecilla (exclusive brand worldwide of our Hospital) have been referenced in more […]
The following session of the program of lectures Valdecilla Progress Reports will take place on February 14 and it will be given by Nerea Iturrioz and Inmaculada Perez del Molino who will present their scientific advances of their current projects. Speaker: Nerea Iturrioz Rodríguez Session: “Carbon nanotubes coated particles as a possible delivery system” Nerea […]
Mutua Madrileña Foundation has opened its program of grants for accredited Health Research Institutes. A maximum of 15 grants will be granted to clinical studies that are developed in Accredited Health Research Institutes (IIS). Each accredited Health Research Institute (IIS) may present a single project in each of the research areas covered by this call […]
The Nano World Cancer Day 2018 is an event organized in the framework of the World Cancer Day (February 2nd). It aims to amplify awareness about Nanomedicine and its ability to introduce new opportunities and game changers in the fight against cancer. Initiated in 2013, the Nano World Cancer Day is an event organized by […]
Three schools, Sagrado Corazón (Esclavas), La Salle and La Marina in Bezana, have completed the first phase of the SWI project that IDIVAL carries out in Cantabria. The project involves involving pre-university students (Secondary and high school) in a real research project, aimed at solving one of the most serious human health problems we face: […]
The Health Institute Carlos III has funded the project “Evolutionary study at 5 years in a population with mild cognitive impairment (MCI) previously evaluated with 11C-PIB and 18F-FDG PET / CT” in the call Health Strategic Action 2016, PI 16/01656. The project is led by Dr. Julio Jiménez-Bonilla, Facultative of the Nuclear Medicine Service of […]
